For IL-9 and IL-17 a significant decline of the serum levels has been shown after 3 months of systemic MTX therapy in patients with psoriasis (18) and furthermore IL-9 serum levels were decreased after treatment with glucocorticoids in patients with systemic lupus erythematosus (19). The gene discussed is IL17A; the disease is psoriasis.